首页> 外文OA文献 >Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials

【2h】

Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials

机译：溴琼酱和末端抑制剂治疗血液恶性肿瘤和实体瘤的安全性和有效性：临床试验的系统研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yanli Sun; Jie Han; Zhanzhao Wang; Xuening Li; Yanhua Sun; Zhenbo Hu;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. ZEN3365 is a novel BET bromodomain inhibitor for the treatment of hematologic malignancies and solid tumors [J] . McLure K. G., Jahagirdar R., Kharenko O. A., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第Suppla6期

机译：ZEN3365是一种新型的BET溴结构域抑制剂，用于治疗血液系统恶性肿瘤和实体瘤
2. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors. [J] . Di Cosimo S, Ferretti G, Papaldo P, Drugs of today: Medicamentos de actualidad . 2003,第3期

机译：Lonidamine：治疗实体肿瘤的临床试验中的功效和安全性。
3. Efficacy and safety of pharmacological treatments for patent ductus arteriosus closure: A systematic review and network meta-analysis of clinical trials and observational studies [J] . Marconi Ettore, Bettiol Alessandra, Ambrosio Giuseppe, Pharmacological research: The official journal of The Italian Pharmacological Society . 2019,第期

机译：专利导管药物治疗的疗效和安全性闭合：临床试验和观察研究的系统综述与网络荟萃分析
4. Characterization of a Small Molecule IRAK4 Inhibitor for the Treatment of Inflammatory Disorders and Hematologic Malignancies [C] . Chrystelle Lamagna, Meagan Chan, Sothy Yi, International Molecular Medicine Tri-Conference. . 2016

机译：用于治疗炎症性疾病和血液性恶性肿瘤的小分子Irak4抑制剂的表征
5. Modernizing the Design of Hematologic Malignancy Clinical Trials [D] . Statler, Abby. 2019

机译：现代化血液学恶性临床试验设计
6. Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials [O] . Yanli Sun, Jie Han, Zhanzhao Wang, 2020

机译：溴琼酱和末端抑制剂治疗血液恶性肿瘤和实体瘤的安全性和有效性：临床试验的系统研究
7. Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis [O] . D Roblin, G Yosipovitch, B Boyce, 2015

机译：局部Trka激酶抑制剂CT327是一种有效的新疗法，用于治疗瘙痒症，由于牛皮癣：实验研究的结果，CT327在牛皮癣患者的2B期临床试验中的实验研究和CT327的疗效和安全性

Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials

著录项

引文网络

相似文献

相关主题

期刊订阅